Followers | 182 |
Posts | 12762 |
Boards Moderated | 0 |
Alias Born | 12/08/2009 |
Monday, March 30, 2020 3:02:47 AM
Punchline:
"These organic growth initiatives are expected to bear fruit over the next few months and begin gaining traction starting Q4 2019 and beyond
Quote:
https://www.globenewswire.com/news-release/2019/06/17/1869664/0/en/GEX-ANNOUNCES-STRATEGIC-INITIATIVES-AND-UPDATES.html
“These organic growth initiatives are expected to bear fruit over the next few months and begin gaining traction starting Q4 2019 and beyond, as we place more consultants and build towards the strength of our strategic relationships. Additionally, our Corporate Strategy team has developed a structured process to identify, review and close potential synergistic acquisition targets that will be complementary to the GEX Management Business Ecosystem. I am very excited to work with our investors, business partners and service providers to continue the positive momentum despite past challenges and am confident of GEX achieving great long term success with this renewed strategy. We will make further announcements to our investors and shareholders as we make progress with these initiatives”.
Let's see what 4th quarter earnings bring they are due tomorrow!! Grab your lottery tickets!!! $GXXM
Recent GXXM News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:53 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 11/13/2023 09:11:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 08:38:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:22:30 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/21/2023 08:00:34 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 02:09:47 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM